Globe Life (GL) Projected to Post Earnings on Wednesday

Globe Life (NYSE:GL) is expected to be announcing its Q3 2026 results after the market closes on Wednesday, October 21st. Analysts expect Globe Life to announce earnings of $4.91 per share and revenue of $1.56 billion for the quarter. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Interested persons may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 22, 2026 at 11:00 AM ET.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%. Globe Life’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company posted $3.05 EPS. On average, analysts expect Globe Life to post $15.70 EPS for the current fiscal year and $16.51 EPS for the next fiscal year.

Globe Life Stock Performance

Shares of Globe Life stock opened at $168.49 on Monday. The firm has a market cap of $12.95 billion, a P/E ratio of 11.19 and a beta of 0.44. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life has a 12 month low of $127.85 and a 12 month high of $191.55. The stock’s fifty day moving average price is $171.45 and its 200-day moving average price is $166.47.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life’s dividend payout ratio is presently 8.76%.

Globe Life declared that its board has approved a share repurchase plan on Monday, August 10th that allows the company to buy back $2.50 billion in outstanding shares. This buyback authorization allows the company to purchase up to 17.7% of its stock through open market purchases. Share buyback plans are generally an indication that the company’s management believes its stock is undervalued.

Analyst Ratings Changes

A number of research analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of Globe Life from $193.00 to $195.00 and gave the company an “overweight” rating in a research report on Thursday. Piper Sandler upped their price target on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. TD Cowen lifted their price objective on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Finally, Morgan Stanley reduced their price objective on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a research note on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $189.56.

Insiders Place Their Bets

In other news, EVP Robert Hensley sold 10,000 shares of the stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the completion of the sale, the executive vice president owned 12,384 shares in the company, valued at approximately $2,106,146.88. This represents a 44.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Thomas Kalmbach sold 21,000 shares of the firm’s stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares of the company’s stock, valued at $9,105,274.08. The trade was a 29.34% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 143,650 shares of company stock worth $25,793,717. 2.11% of the stock is currently owned by company insiders.

Globe Life Company Profile

Globe Life Inc (NYSE: GL) is an insurance holding company that provides life and supplemental health insurance products to individuals and families in the United States. Its offerings include term and whole life insurance, mortgage protection coverage, accident and supplemental health policies, and Medicare supplement insurance.

The company distributes its products through a network of insurance agencies, independent agents, and direct-to-consumer channels. Its principal insurance businesses include Globe Life and Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, and Family Heritage Life Insurance Company.